Dabigatran Impurity Q-d4 |
|
| Synonyms: Ethyl 3-(3-Amino-N-(pyridin-2-yl)benzamido)propanoate-d4; Ethyl 3-(3-Amino-N-(pyridin-2-yl)benzamido)propanoate-d4 | |
| Cat. No.: D00195 | CAS No.: N.A |
| MDL.: | Formula: C17H15D4N3O3 |
| F.W.317.38 | Purity: 99% |
| Storage: No Data Available | |
|   | |
| Catalog Number: | D00195 | CAS No.: | N.A | |
| MDL: | Formula: | C17H15D4N3O3 | ||
| F.W.: | 317.38 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005), | |||
| Application: | Isotope labelled Ethyl 3-(3-amino-N-(pyridin-2-yl)benzamido)propanoate is an impurity in the synthesis of Dabigatran, a nonpeptide, direct thrombin inhibitor. Antithrombotic. | |||
| Category: | Aromatics, Heterocycles, Isotope Labelled Compounds, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals | |||








